Meeting News

Offer acceptance of older donor liver for transplant lowers mortality risk

October 22, 2018
Patients with advanced liver disease who accept donor livers from individuals older than 70 years significantly reduced their long-term mortality…

Ravidasvir for HCV added to Chinese FDA priority review list

October 22, 2018
The Chinese Food and Drug Administration added Ascletis’ hepatitis C NS5A inhibitor ravidasvir to the list of proposed priority review to…
Meeting News

Vibrating capsule effective for chronic idiopathic constipation

October 22, 2018
PHILADELPHIA — An orally administered, intraluminal capsule appeared effective for the treatment of chronic idiopathic constipation, according…
Meeting News

Short hospital length of stay linked to cirrhosis-related readmission

October 22, 2018
PHILADELPHIA — The 30-day readmission rate among patients with cirrhosis was 55% in a recent study and was tied to short hospital length of…
In the Journals

Frequently eating organic food may lower cancer risk

October 22, 2018
Researchers observed a significant reduction in overall risk of cancer among individuals who consumed organic food at a high frequency, according to…

Liver disease highlights from ACG 2018

October 20, 2018
This year at the American College of Gastroenterology Annual Meeting, several hepatology specialists discussed the changing landscape of liver…
Meeting News

Women more likely to experience key side effects from chemotherapy for esophagogastric cancer

October 20, 2018
MUNICH — Women appeared more likely than men to experience certain side effects from first-line chemotherapy for esophagogastric cancer…
Meeting News

Rectal indomethacin dose escalation ineffective for post-ERCP pancreatitis prevention

October 19, 2018
PHILADELPHIA — Rectal indomethacin dose escalation in high-risk patients undergoing endoscopic retrograde cholangiopancreatography did not…
FDA News

FDA advisory committee votes unanimously in favor of approval of prucalopride for chronic idiopathic constipation

October 19, 2018
By a 10-0 vote, the FDA Gastrointestinal Drugs Advisory Committee voted to approve prucalopride for chronic idiopathic constipation, according to a…

Institutions use transarterial radioembolization for pediatric liver cancer

October 19, 2018
A team of physicians from the Baylor College of Medicine and the Texas Children’s Cancer Center’s Pediatric Liver Tumor Program have…
Meeting News

One-third of ‘gluten-free’ restaurant food contains gluten

October 19, 2018
PHILADELPHIA — As much as one-third of food labeled as gluten-free in restaurants are contaminated with gluten, according to research presented…
Meeting News

Elderly-onset ulcerative colitis increases mortality risk

October 18, 2018
PHILADELPHIA — Patients who were diagnosed with ulcerative colitis at a later age had an increased risk for mortality compared with patients…
Meeting News

NSAID, aspirin use increases microscopic colitis risk

October 18, 2018
PHILADELPHIA – Use of nonsteroidal anti-inflammatory drugs and aspirin — but not acetaminophen — correlated with an increased risk…
Meeting News

Entyvio safely treats immunotherapy-induced enterocolitis

October 18, 2018
PHILADELPHIA – Treatment with Entyvio for immunotherapy-induced enterocolitis demonstrated favorable outcomes and a good safety profile…
Meeting News

Multiple Crohn’s strictures lead to poor balloon dilation response

October 18, 2018
PHILADELPHIA — Patients with multiple Crohn’s disease-associated strictures experience less success with endoscopic balloon dilation…

SLACK Incorporated Appoints Matt Holland Chief Commercial Officer

October 18, 2018
SLACK Incorporated, a Wyanoke Group Company, is pleased to announce Matthew J. Holland as Chief Commercial Officer. Holland will oversee print…

Healio honors Disruptive Innovators at ACG 2018

October 17, 2018
PHILADELPHIA — Healio Gastroenterology and Liver Disease unveiled its inaugural Disruptive Innovators Awards recipients at the American…
Meeting News

Xeljanz appears safe, effective for long-term ulcerative colitis treatment

October 17, 2018
PHILADELPHIA — Xeljanz, an oral Janus kinase inhibitor, showed efficacy and safety in the treatment of ulcerative colitis in a 24-month, open…
Meeting News

Combination immunotherapy may increase liver injury risk

October 17, 2018
PHILADELPHIA – Patients who received treatment with multiple immunotherapy drugs had increased risks for drug-induced liver injury compared…
Meeting NewsVideo

VIDEO: Multi-target stool DNA test reliably detects colorectal cancer

October 17, 2018
PHILADELPHIA – In this exclusive video perspective from the American College of Gastroenterology Annual Meeting, John B. Kisiel